A Multi-Arm, Platform Trial For Relapsed Neuroblastoma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(23 sites)
Australia
Sydney Children's Hospital (SCH), Sydney Austria
St. Anna Children´s Hospital, Vienna Belgium
Cliniques Universitaires Saint-Luc (CUSL), Brussels New Zealand
Starship Children's Hospital (SSH), Auckland United Kingdom
Royal Aberdeen Children's Hospital, Aberdeen Royal Belfast Hospital for Sick Children, Belfast Birmingham Children's Hospital, Birmingham Bristol Royal Hospital for Children, Bristol Addenbrookes Hospital, Cambridge Children's Hospital for Wales, Cardiff Royal Hospital for Sick Children, Edinburgh Royal Hospital for Children, Glasgow Leeds General Infirmary, Leeds Alder Hey Hospital, Liverpool Great Ormond Street Hospital, London University College London Hospital, London Royal Manchester Children's Hospital, Manchester Royal Victoria Infirmary, Newcastle upon Tyne
Nottingham Children's Hospital, Nottingham John Radcliffe Hospital, Oxford Sheffield Children's Hospital, Sheffield Southampton General Hospital, Southampton Royal Marsden Hospital, Sutton